Product
MBA-P01
2 clinical trials
1 indication
Indication
Glabellar Frown LinesClinical trial
Open-label, Single Group, Multi-center, Repeat-dose Long-term Extension Study to Evaluate the Long-term Safety and Efficacy of MBA-P01 in Subjects With Moderate to Severe Glabellar LinesStatus: Completed, Estimated PCD: 2023-05-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar LinesStatus: Completed, Estimated PCD: 2022-06-22